{"id":1364,"date":"2018-07-09T18:55:45","date_gmt":"2018-07-09T18:55:45","guid":{"rendered":"http:\/\/blog.valuengine.com\/?p=1364"},"modified":"2018-07-09T18:55:45","modified_gmt":"2018-07-09T18:55:45","slug":"top-valuengine-upgrades-for-the-day","status":"publish","type":"post","link":"http:\/\/blog.valuengine.com\/index.php\/top-valuengine-upgrades-for-the-day\/","title":{"rendered":"Top ValuEngine Upgrades For The Day"},"content":{"rendered":"

For today’s bulletin, we take a look at our latest BUY and STRONG BUY upgrades. We also provide a link to download a FREE STOCK REPORT on one of our top upgrades for the day, Care.com $CRCM.<\/strong><\/span><\/p>\n

VALUATION WATCH: Overvalued stocks now make up 50.04% of our stocks assigned a valuation and 19.21% of those equities are calculated to be overvalued by 20% or more. Ten sectors are calculated to be overvalued.<\/strong><\/span>
\n <\/p>\n

For today’s edition of our upgrade list, we used our website’s advanced screening functions<\/a><\/strong> to search for UPGRADES to BUY or STRONG BUY with complete forecast and valuation data. They are presented by one-month forecast return. ALL of our upgrades for today are rated STRONG BUY with the exception of Aptevo Therapeutics. Aptevo is rated BUY..<\/p>\n\n\n\n\n\n\n\n\n
Ticker<\/strong><\/td>\nCompany Name<\/strong><\/td>\nMarket Price<\/strong><\/td>\nValuation<\/strong><\/td>\nLast 12-M Return<\/strong><\/td>\n1-M Forecast Return<\/strong><\/td>\n1-Yr Forecast Return <\/strong><\/td>\nP\/E Ratio<\/strong><\/td>\nSector Name<\/strong><\/td>\n<\/tr>\n
AMSWA<\/td>\nAMER SOFTWARE A<\/td>\n16.28<\/td>\n54.27%<\/td>\n62.96%<\/td>\n1.10%<\/td>\n13.25%<\/td>\n48.36<\/td>\nComputer and Technology<\/td>\n<\/tr>\n
MB<\/td>\nMINDBODY INC-A<\/td>\n41.55<\/td>\n40.48%<\/td>\n64.55%<\/td>\n1.10%<\/td>\n13.21%<\/td>\nN\/A<\/td>\nComputer and Technology<\/td>\n<\/tr>\n
CRCM<\/td>\nCARE.COM INC<\/td>\n21.69<\/td>\n57.80%<\/td>\n53.83%<\/td>\n1.09%<\/td>\n13.14%<\/td>\n67.78<\/td>\nConsumer Discretionary<\/td>\n<\/tr>\n
NEOG<\/td>\nNEOGEN CORP<\/td>\n83.75<\/td>\n42.62%<\/td>\n66.14%<\/td>\n1.09%<\/td>\n13.06%<\/td>\n69.99<\/td>\nMedical<\/td>\n<\/tr>\n
APVO<\/td>\nAPTEVO THERAPS<\/td>\n5.09<\/td>\nN\/A<\/td>\n165.10%<\/td>\n0.68%<\/td>\n8.11%<\/td>\nN\/A<\/td>\nMedical<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Want to learn more about ValuEngine? Our methods? Our history? <\/strong><\/span>
\n Check out our video presentation HERE<\/a><\/strong><\/span><\/p>\n

Care.com, Inc. (CRCM) provides online marketplace for finding and managing family care primarily in the United States and internationally. Its platform provides care needs which consists of child care, senior care and special needs care as well as other non-medical family care needs such as pet care, tutoring and housekeeping and helps caregivers find employment opportunities. Care.com, Inc. is based in Waltham, Massachusetts.<\/p>\n

This company had decent results the last time they reported in May. Q1 results showed revenue of $47.3 million, an increase of 9% from $43.4 million in the first quarter of 2017. Net income was $2.7 million, compared to $0.8 million in the first quarter of 2017, an improvement of $1.9 million. GAAP EPS (Diluted) was $0.05, compared to $0.01 in the first quarter of 2017.<\/p>\n

\u201cWe had a strong first quarter of 2018, with both revenue and EBITDA exceeding our expectations \u2013 and generated an incremental $5 million in cash,\u201d said Sheila Lirio Marcelo, Founder, Chairwoman and CEO of Care.com. \u201cAs we look ahead to 2018, we will continue to focus on initiatives that we expect will drive long-term profitable growth, with the goal of accelerating our top line in 2019 and beyond.\u201d<\/p>\n

ValuEngine updated its recommendation from BUY to STRONG BUY for CARE.COM INC on 2018-07-06. Based on the information we have gathered and our resulting research, we feel that CARE.COM INC has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE Momentum and Earnings Growth Rate.<\/p>\n

You can download a free copy of detailed report on Care.com, Inc. (CRCM) from the link below.<\/p>\n

<\/p>\n\n\n\n\n\n\n\n\n\n\n
ValuEngine Forecast<\/strong><\/td>\n<\/tr>\n
<\/td>\nTarget
\nPrice*<\/th>\n		Expected
\nReturn<\/th>\n<\/tr>\n
1-Month<\/strong><\/td>\n21.93<\/td>\n1.09%<\/td>\n<\/tr>\n
3-Month<\/strong><\/td>\n22.30<\/td>\n2.83%<\/td>\n<\/tr>\n
6-Month<\/strong><\/td>\n23.04<\/td>\n6.22%<\/td>\n<\/tr>\n
1-Year<\/strong><\/td>\n24.54<\/td>\n13.14%<\/td>\n<\/tr>\n
2-Year<\/strong><\/td>\n26.16<\/td>\n20.59%<\/td>\n<\/tr>\n
3-Year<\/strong><\/td>\n26.26<\/td>\n21.08%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Valuation & Rankings<\/strong><\/td>\n<\/tr>\n
Valuation<\/strong><\/td>\n57.80% overvalued<\/td>\nValuation Rank<\/strong>(?<\/a>)<\/td>\n6<\/td>\n<\/tr>\n
1-M Forecast Return<\/strong><\/td>\n1.09%<\/td>\n1-M Forecast Return Rank<\/strong><\/td>\n99<\/td>\n<\/tr>\n
12-M Return<\/strong><\/td>\n53.83%<\/td>\nMomentum Rank<\/strong>(?<\/a>)<\/td>\n90<\/td>\n<\/tr>\n
Sharpe Ratio<\/strong><\/td>\n-0.15<\/td>\nSharpe Ratio Rank<\/strong>(?<\/a>)<\/td>\n34<\/td>\n<\/tr>\n
5-Y Avg Annual Return<\/strong><\/td>\n-7.21%<\/td>\n5-Y Avg Annual Rtn Rank<\/strong><\/td>\n30<\/td>\n<\/tr>\n
Volatility<\/strong><\/td>\n48.74%<\/td>\nVolatility Rank<\/strong>(?<\/a>)<\/td>\n33<\/td>\n<\/tr>\n
Expected EPS Growth<\/strong><\/td>\n46.88%<\/td>\nEPS Growth Rank<\/strong>(?<\/a>)<\/td>\n72<\/td>\n<\/tr>\n
Market Cap (billions)<\/strong><\/td>\n0.68<\/td>\nSize Rank<\/strong><\/td>\n55<\/td>\n<\/tr>\n
Trailing P\/E Ratio<\/strong><\/td>\n67.78<\/td>\nTrailing P\/E Rank<\/strong>(?<\/a>)<\/td>\n34<\/td>\n<\/tr>\n
Forward P\/E Ratio<\/strong><\/td>\n46.15<\/td>\nForward P\/E Ratio Rank<\/strong><\/td>\n9<\/td>\n<\/tr>\n
PEG Ratio<\/strong><\/td>\n1.45<\/td>\nPEG Ratio Rank<\/strong><\/td>\n26<\/td>\n<\/tr>\n
Price\/Sales<\/strong><\/td>\n3.82<\/td>\nPrice\/Sales Rank<\/strong>(?<\/a>)<\/td>\n29<\/td>\n<\/tr>\n
Market\/Book<\/strong><\/td>\n23.48<\/td>\nMarket\/Book Rank<\/strong>(?<\/a>)<\/td>\n7<\/td>\n<\/tr>\n
Beta<\/strong><\/td>\n1.07<\/td>\nBeta Rank<\/strong><\/td>\n33<\/td>\n<\/tr>\n
Alpha<\/strong><\/td>\n0.20<\/td>\nAlpha Rank<\/strong><\/td>\n83<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

DOWNLOAD A FREE SAMPLE OF OUR CARE.COM (CRCM) REPORT BY CLICKING HERE <\/a><\/strong><\/em><\/p>\n

 <\/p>\n

ValuEngine.com is an Independent Research Provider (IRP), producing buy\/hold\/sell recommendations, target price, and valuations on over 5,000 US and Canadian equities every trading day.<\/strong><\/span>
\n Contact ValuEngine at (321) 325-0519 or support@valuengine.com \u00a0<\/strong><\/span>
\n Visit www.ValuEngine.com for more information<\/a><\/strong><\/span><\/p>\n

\u00a0<\/strong><\/span><\/h1>\n

ValuEngine Capital Management LLC is a Registered Investment Advisory (RIA) firm that trades client accounts using ValuEngine’s award-winning stock research. <\/strong><\/span>
\n Contact ValuEngine Capital at info@valuenginecapital.com<\/strong><\/span>
\n Visit www.ValuEngineCapital.com for more information<\/a><\/strong><\/span><\/p>\n

\u00a0<\/strong><\/span><\/h1>\n

Steve Hach
\nSenior Editor
\nValuEngine.Com<\/em><\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

For today’s bulletin, we take a look at our latest BUY and STRONG BUY upgrades. We also provide a link to download a FREE STOCK REPORT on one of our top upgrades for the day, Care.com $CRCM. VALUATION WATCH: Overvalued stocks now make up 50.04% of our stocks assigned a valuation and 19.21% of those … Read more<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[1237,1232,1235,1234,1236,1233,9,7,1054,28],"_links":{"self":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/1364"}],"collection":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/comments?post=1364"}],"version-history":[{"count":1,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/1364\/revisions"}],"predecessor-version":[{"id":1365,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/1364\/revisions\/1365"}],"wp:attachment":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/media?parent=1364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/categories?post=1364"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/tags?post=1364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}